An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants.
Huang L, Zhao F, He M, Fang Y, Ma X, Lu S, Li E, Xiao H, Zhu H, Wang X, Tang S, Yu B, Wang J, Zhao D, Wang C, Li H, Gao Y, Peng X, Shen H.
Huang L, et al. Among authors: wang x, wang j, wang c.
J Control Release. 2024 Feb;366:479-493. doi: 10.1016/j.jconrel.2024.01.002. Epub 2024 Jan 11.
J Control Release. 2024.
PMID: 38184234